Parkinson's disease and enhanced inflammatory response

被引：126
|
作者：
Stojkovska, Iva [1 ]
Wagner, Brandon M. [1 ]
Morrison, Brad E. [1 ]
机构：
[1] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA
来源：
EXPERIMENTAL BIOLOGY AND MEDICINE | 2015年 / 240卷 / 11期
关键词：
Parkinson's disease; neuroinflammation; inflammation; disease models; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BLOOD-BRAIN-BARRIER; SYNUCLEIN TRANSGENIC MICE; ALPHA-SYNUCLEIN; MICROGLIAL ACTIVATION; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; MITOCHONDRIAL DYSFUNCTION; INTRANIGRAL INJECTION; INTERFERON-GAMMA;
D O I：
10.1177/1535370215576313
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Parkinson's disease (PD) is the first and second most prevalent motor and neurodegenerative disease, respectively. The clinical symptoms of PD result from a loss of midbrain dopaminergic (DA) neurons. However, the molecular cause of DA neuron loss remains elusive. Mounting evidence implicates enhanced inflammatory response in the development and progression of PD pathology. This review examines current research connecting PD and inflammatory response.
引用
收藏
页码：1387 / 1395
页数：9
相关论文
共 50 条
  • [21] Inflammatory changes and apoptosis in Parkinson's disease
    Hirsch, EC
    MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE, 2002, 51 : 259 - 263
  • [22] Oxidative and Inflammatory Pathways in Parkinson's Disease
    Miller, Rebecca L.
    James-Kracke, Marilyn
    Sun, Grace Y.
    Sun, Albert Y.
    NEUROCHEMICAL RESEARCH, 2009, 34 (01) : 55 - 65
  • [23] High-intensity interval training modulates inflammatory response in Parkinson's disease
    Paulina, Malczynska-Sims
    Malgorzata, Chalimoniuk
    Zbigniew, Wronski
    Jaroslaw, Marusiak
    Anna, Sulek
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (09) : 2165 - 2176
  • [24] Inflammatory Response Modulation by Vitamin C in an MPTP Mouse Model of Parkinson's Disease
    De Nuccio, Francesco
    Cianciulli, Antonia
    Porro, Chiara
    Kashyrina, Marianna
    Ruggiero, Melania
    Calvello, Rosa
    Miraglia, Alessandro
    Nicolardi, Giuseppe
    Lofrumento, Dario Domenico
    Panaro, Maria Antonietta
    BIOLOGY-BASEL, 2021, 10 (11):
  • [25] Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
    Laura Muñoz-Delgado
    Daniel Macías-García
    María Teresa Periñán
    Silvia Jesús
    Astrid D. Adarmes-Gómez
    Marta Bonilla Toribio
    Dolores Buiza Rueda
    María del Valle Jiménez-Jaraba
    Belén Benítez Zamora
    Rafael Díaz Belloso
    Sergio García-Díaz
    Miguel Martín-Bórnez
    Rocío Pineda Sánchez
    Fátima Carrillo
    Pilar Gómez-Garre
    Pablo Mir
    npj Parkinson's Disease, 9
  • [26] High-intensity interval training modulates inflammatory response in Parkinson’s disease
    Paulina Malczynska-Sims
    Małgorzata Chalimoniuk
    Zbigniew Wronski
    Jaroslaw Marusiak
    Anna Sulek
    Aging Clinical and Experimental Research, 2022, 34 (9) : 2165 - 2176
  • [27] The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease
    Joglar, Belen
    Rodriguez-Pallares, Jannette
    Isabel Rodriguez-Perez, Ana
    Rey, Pablo
    Jose Guerra, Maria
    Luis Labandeira-Garcia, Jose
    JOURNAL OF NEUROCHEMISTRY, 2009, 109 (02) : 656 - 669
  • [28] Response slowing in Parkinson's disease
    Low, KA
    Miller, J
    Vierck, E
    BRAIN, 2002, 125 : 1980 - 1994
  • [29] Genetics of Parkinson's disease - Response
    Polymeropoulos, MH
    SCIENCE, 1997, 278 (5341) : 1213 - 1213
  • [30] The placebo response in Parkinson's disease
    Shetty, N
    Friedman, JH
    Kieburtz, K
    Marshall, FJ
    Oakes, D
    CLINICAL NEUROPHARMACOLOGY, 1999, 22 (04) : 207 - 212
12345